Artelo Biosciences, Inc.
ARTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621221
No open-market purchases or sales by Artelo Biosciences, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $132.0K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 10
- 13F valueReported value at the end of Q2 2026
- $132.0K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ARTL, Q2 2026
No superinvestor reported holding ARTL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Artelo Biosciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 (view filing) | May 1 | 4 days | Seymour Tamara ADirector | PPurchaseConvertible Promissory Note | – | – | – | – | DerivativePrice outlier |
| May 5, 2025 (view filing) | May 1 | 4 days | Matsui ConnieDirector | PPurchaseConvertible Promissory Note | – | – | – | – | DerivativePrice outlier |
| May 5, 2025 (view filing) | May 1 | 4 days | Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr | PPurchaseConvertible Promissory Note | – | – | – | – | DerivativePrice outlier |
| Aug 12, 2022 (view filing) | Aug 12 | Same day | Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr | PPurchase | +1.20K | $4.00 | +$4.80K | +100.0%2.40K after | |
| Aug 11, 2022 (view filing) | Aug 11 | Same day | Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr | PPurchase | +1.20K | $4.03 | +$4.84K | New position1.20K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Artelo Biosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 66,341 | $74.3K | 0.00% | +53,262+407.2% | Added |
| Geode Capital Management, LLC | 13,864 | $15.5K | 0.00% | +13,864 | New |
| StoneX Group Inc. | 12,400 | $14.7K | 0.00% | +12,400 | New |
| Vanguard Capital Management LLC | 10,129 | $11.3K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,435 | $9.45K | 0.00% | +5,609+198.5% | Added |
| Vanguard Fiduciary Trust Co | 3,139 | $3.52K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,804 | $3.14K | 0.00% | +2,804 | New |
| Rothschild Investment LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 2 | $2 | 0.00% | +2 | New |
| Danske Bank A/S | 1 | $1 | 0.00% | +1 | New |